Botros B A, Sobh M, Wierzba T, Arthur R R, Mohareb E W, Frenck R, El Refaie A, Mahmoud I, Chapman G D, Graham R R
U.S. Naval Medical Research Unit No. 3, Code 303, BAB, PSC 452, Box 5000, FPO AE 09835-0007, Cairo, Egypt.
Trans R Soc Trop Med Hyg. 2004 Jun;98(6):331-6. doi: 10.1016/S0035-9203(03)00063-4.
In Egypt, the etiology of chronic renal failure (CRF) is not well defined. A hospital-based case-control study was initiated in February 1998, to determine whether hantavirus infection is involved in chronic renal disease (CRD) in Egypt. The study enrolled 350 study patients with a history of CRF and 695 matched controls with CRD due to renal calculus or renal cancer, but with normal renal functions. Sera from cases and controls were tested for anti-hantavirus IgG using ELISA with a cell-lysate antigen from Hantaan virus prototype strain 76-118. A demographic questionnaire was completed for each study participant. Five of the 350 cases (1.4%), and seven of the 695 controls (1.0%) were antibody-positive to hantavirus, with a titer > or =1:400. The difference in antibody prevalence between the study cases and the control cases was not statistically significant (P = 0.48). All antibody-positive study cases and controls had been exposed to rodents. Data indicated that in Egypt, hantavirus seroprevalence in CRD patients is low, and hantavirus infections do not appear to be a significant cause of CRF.
在埃及,慢性肾衰竭(CRF)的病因尚不明确。1998年2月启动了一项基于医院的病例对照研究,以确定汉坦病毒感染是否与埃及的慢性肾病(CRD)有关。该研究招募了350名有慢性肾衰竭病史的研究患者和695名因肾结石或肾癌导致慢性肾病但肾功能正常的匹配对照。使用来自汉坦病毒原型株76 - 118的细胞裂解物抗原,通过酶联免疫吸附测定(ELISA)对病例组和对照组的血清进行抗汉坦病毒IgG检测。为每位研究参与者填写了一份人口统计学调查问卷。350例病例中有5例(1.4%),695例对照中有7例(1.0%)对汉坦病毒抗体呈阳性,滴度≥1:400。研究病例与对照病例之间抗体流行率的差异无统计学意义(P = 0.48)。所有抗体呈阳性的研究病例和对照均曾接触过啮齿动物。数据表明,在埃及,慢性肾病患者中汉坦病毒血清阳性率较低,汉坦病毒感染似乎不是慢性肾衰竭的重要病因。